Peter Impey

London, UK
Email: peter.impey@bairdscmc.com

Linkedin: uk.linkedin.com/in/peterimpey

Peter Impey is a senior communications consultant. He has national and international experience in a wide range of healthcare communication disciplines. He started his career in sales and marketing at P&G before moving into the healthcare communications field where he has worked for leading consultancies, including Ketchum, Virgo and Ruder Finn. He currently works at 90TEN healthcare where he leads the international practice and innovation arm of the agency. His work has won numerous awards, for their creativity and focus on achieving outcomes.

Peter has a degree in pharmacology from King’s College London along with broad disease area experience including, atrial fibrillation, BPH, cholesterol management, contraception, dermatology, diabetes, erectile dysfunction, epilepsy, gout, hearing loss, heart failure, hepatitis, HIV, liver cancer, malaria, meningitis, OAB, osteoarthritis, osteoporosis, pain, pandemic and seasonal influenza, rheumatoid arthritis, schizophrenia, tinnitus and travel vaccines.

Roles

• Associate at Baird’s CMC
• Director at 90TEN
• Director at denovo Strategy

Areas of expertise:

• Healthcare communications expertise in public health and pharmaceuticals/devices, including media relations, advocacy, stakeholder engagement, issues management, CSR and corporate communications
• Use of emerging technology and application of innovation methodologies to deliver truly creative communications campaigns

Project examples:

• Award-winning meningitis campaign that was one of the first in the pharmaceutical industry to use Facebook to its full extent
• PAG coalition to lead a global call to action enabling young people to make informed choices on their sexual and reproductive health
• Global crisis communications during the 2009 influenza pandemic

Client examples:

Allergan, Novartis, Roche, Bayer, Sanofi, Merck, Eli Lilly, AstraZeneca, Sirtex, GSK, Pfizer, BMS, Gilead, J&J, Roll Back Malaria, Malaria No More, Novartis Foundation, Action on Hearing Loss, Meningitis Now and the Meningitis Research Foundation.